CIK 0000014272 · Large accelerated filer
BRISTOL MYERS SQUIBB CO
Sign in to watch- Ticker
- BMY
- Exchange
- NYSE
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 220790350
- Phone
- 6092524621
- Business address
- ROUTE 206 AND PROVINCE LINE ROAD, PRINCETON, NJ, 08543
Securities
- BMY Bristol-Myers Squibb Company Common Stock NYSE
- CELG-RI Rights NYSE
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $677,826
- in 3 filings
Net −$677,826. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-03-10 | Hirawat Samit EVP,Chief Med.Offr.,Drug Dev. | Option exercise | +4,192 | 51,437 | ||
| 2024-03-10 | Hirawat Samit EVP,Chief Med.Offr.,Drug Dev. | Other disposition | −660 | 50,777 | ||
| 2024-03-10 | Hirawat Samit EVP,Chief Med.Offr.,Drug Dev. | Shares withheld for taxes | −1,807 | $53.79 | $97K | 48,970 |
| 2024-03-10 | Hirawat Samit EVP,Chief Med.Offr.,Drug Dev. | Option exercise | +4,885 | 53,855 | ||
| 2024-03-10 | Hirawat Samit EVP,Chief Med.Offr.,Drug Dev. | Other disposition | −842 | 53,013 | ||
| 2024-03-10 | Hirawat Samit EVP,Chief Med.Offr.,Drug Dev. | Shares withheld for taxes | −2,068 | $53.79 | $111K | 50,945 |
| 2024-03-10 | Hirawat Samit EVP,Chief Med.Offr.,Drug Dev. | Option exercise | +29,311 | 80,256 | ||
| 2024-03-10 | Hirawat Samit EVP,Chief Med.Offr.,Drug Dev. | Other disposition | −10,203 | 70,053 | ||
| 2024-03-10 | Hirawat Samit EVP,Chief Med.Offr.,Drug Dev. | Shares withheld for taxes | −9,774 | $53.79 | $526K | 60,279 |
| 2024-03-10 | Hirawat Samit EVP,Chief Med.Offr.,Drug Dev. | Option exercise · Market Share Units | −4,192 | 0 | ||
| 2024-03-10 | Hirawat Samit EVP,Chief Med.Offr.,Drug Dev. | Option exercise · Market Share Units | −4,885 | 4,886 | ||
| 2024-03-10 | Hirawat Samit EVP,Chief Med.Offr.,Drug Dev. | Other disposition · Market Share Units | −4,765 | 9,532 | ||
| 2024-03-10 | Hirawat Samit EVP,Chief Med.Offr.,Drug Dev. | Other disposition · Market Share Units | −5,854 | 17,565 | ||
| 2024-03-10 | Hirawat Samit EVP,Chief Med.Offr.,Drug Dev. | Grant or award · Market Share Units | +40,635 | 40,635 | ||
| 2024-03-10 | Hirawat Samit EVP,Chief Med.Offr.,Drug Dev. | Option exercise · Performance Shares | −29,311 | 0 | ||
| 2024-03-10 | Hirawat Samit EVP,Chief Med.Offr.,Drug Dev. | Grant or award · Performance Shares | +60,952 | 60,952 | ||
| 2024-03-10 | Holzer Phil M SVP and Controller | Option exercise | +613 | 10,624 | ||
| 2024-03-10 | Holzer Phil M SVP and Controller | Other disposition | −97 | 10,527 | ||
| 2024-03-10 | Holzer Phil M SVP and Controller | Shares withheld for taxes | −187 | $53.79 | $10K | 10,340 |
| 2024-03-10 | Holzer Phil M SVP and Controller | Option exercise | +701 | 11,041 |
Page 33 of 40 · 799 trades